Search Transactions

By Industry

By Type

Industry: Healthcare (Click tombstones for transaction details)

Mirus Capital Advisors served as financial advisor to Applied BioMath on its acquisition by Certara (Nasdaq: CERT)

Mirus advised Jaco, Inc. in its sale to GCX Mounting Solutions (“GCX”), a portfolio company of Audax Private Equity (“Audax”) and a global leader in the design and manufacturing of healthcare-focused mounting and mobility solutions.

Mirus Capital Advisors is pleased to announce that it served as the exclusive financial advisor to TheraCell, Inc., a California based orthobiologics company, in its sale to Isto Biologics. Isto...

Mirus acted as exclusive financial advisor to AdvanSource in its transaction with Mitsubishi Chemical Performance Polymers.

Mirus Capital Advisors served as exclusive financial advisor to Esco Technologies LLC in its sale to Periscope Equity as part of its Sentrics healthcare technology and security platform. About Esco ESCO Technologies...

Mirus Capital Advisors acted as the exclusive financial advisor to Mobilize RRS in its acquisition by ZOLL® Medical Corporation, an Asahi Kasei Group Company.

Mirus advises Tunstall Healthcare Group in the sale of Tunstall Americas to Connect America

Mirus advised CTGT in its sale to HNL.

Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Bio2 Technologies, Inc. (Bio2) in securing its Series C equity financing which was led by DSM...

Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Belmont Instrument Corporation (“Belmont”), in its recapitalization with Audax Private Equity (“Audax”). Belmont is a leading...

Hayes Management Consulting has completed a management buy-out of its founding shareholder with financing from Seacoast Capital and Cambridge Savings Bank.

Mirus Capital Advisors announced that Liberating Technologies Inc., (LTI) a leading provider of powered upper limb prosthetics, located in Holliston, Massachusetts, has been acquired by College Park Industries Inc.

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced that it has sold its M-Vu Breast Density software to iCAD, Inc.

Mirus Capital Advisors announced that BioPharm Engineered Systems, Inc. (“BPES”) has been acquired by Critical Process Systems Group of Colchester, Vermont.

Mirus Capital Advisors announced today that it has provided a fairness opinion to the board of RedPath Integrated Pathology, Inc.

VWR (NASDAQ: VWR) has expanded its portfolio of product offerings to the life science and biopharmaceutical industries through its acquisition of bioprocessing single-use system integrator, Integra Companies, Inc.

Mirus advised B&V Testing and its owner Peter Harris on the sale of his business to Stericycle

Mirus advised BioModels on an investment from NoAb Biodiscoveries

Mirus advised Apple Medical Corporation on a sale to CooperSurgical, Inc.

Alan Fullerton advised Glamox on the sale of lighting company Burton to Philips

Nyer Medical Group has sold Eaton Apothecary to Walgreens.

TiGenix announced that it has acquired Orthomimetics, a privately held medical technology company based in the United Kingdom.

Mirus advised the management and shareholders of American Biological Technologies on a sale of the Company to Fujirebio Diagnostics

Alan Fullerton advised Isolation Technologies in a sale of its business to IDEX Corporation.

Alan Fullerton advised Endoscopic Concepts, Inc. in a sale of its assets to U.S. Surgical, now a division of Covidien.

Alan Fullerton advised Biopure (Nasdaq:BPUR), a developer of oxygen therapeutics for veterinary and human use, on its sale to OPK Biotech.

Mirus advised DxCG, a provider of predictive modeling software for Healthcare, in a sale transaction with ISO.

Mirus Securities advised EMFP, Inc. on a Private Placement from Medicapital

Mirus advised Consumer Health on a sale of its business to Call Connect Communications.